Article info

Download PDFPDF
Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis
  1. Professor T Thomas, INSERM U890, Rheumatology Department, University Hospital, Boulevard Pasteur, 42055 SAINT-ETIENNE Cedex2, France; thierry.thomas{at}univ-st-etienne.fr
View Full Text

Citation

Chopin F, Garnero P, le Henanff A, et al
Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis

Publication history

  • Accepted July 10, 2007
  • Final version accepted July 20, 2007
  • First published July 20, 2007.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.